News for Celsion Corporation (0HUZ.L)

Hepatic tumors are abnormal growth of liver cells on or in the liver. The Hepatic Tumor market is driven by several key factors reflecting the increasing...

[220+ Pages Latest Report] According to a market research study published by Custom Market Insights, the demand analysis of Global Lipid Nanoparticles...

A primary driver for the growth of the liver cancer drugs market is the rising incidence of liver cancer globally. Factors contributing to this include the...

/PRNewswire/ -- Roots Analysis has announced the addition of "Non-Viral Transfection Reagents and Systems Market, 2nd Edition, 2023-2035" report to its list of...

/PRNewswire/ -- DelveInsight's Liver Cancer Market Insights report includes a comprehensive understanding of current treatment practices, liver cancer emerging...

The dynamics of the acute lung injury market are anticipated to change in the coming years due to increased awareness of the complication, incremental...

SEATTLE, June 01, 2023 (GLOBE NEWSWIRE) -- Atossa Therapeutics, Inc. (Nasdaq: ATOS), a clinical stage biopharmaceutical company developing innovative...

/PRNewswire/ -- The

Read StockNews.com Initiates Coverage on Imunon (NASDAQ:CLSN) at ETF Daily News

The chemiluminescence immunoassay market is expected to grow due to factors such as rising disease prevalence, such as cancer, diabetes, and cardiovascular...

Read Financial Survey: ImmunoCellular Therapeutics (OTCMKTS:IMUC) vs. Celsion (NASDAQ:CLSN) at ETF Daily News

DelveInsight’s liver cancer pipeline report depicts a robust space with 100+ active players working to develop 100+ pipeline therapies for liver cancer...

Key Companies Covered in the Liposome Drug Delivery Market Research Report By Research Nester Are NIPPON FINE CHEMICAL CO., LTD., Sonic Biochem Extractions...

Celsion Corporation Reports First Quarter 2022 Financial Results and Provides Business Update - read this article along with other careers information, tips and advice on BioSpace

DNA Mediated Immunotherapy and Next-Generation Vaccine Programs Supported with a Strong Balance Sheet Conference Call Begins Today at 11:00 a.m. EDT ...

E xpands GEN-1 P rogram C ollaboration to Add C linical and C ommercial B atches of I nvestigational V accine LAWRENCEVILLE, N.J. and HAINAN,

Expands GEN-1 Program Collaboration to Add Clinical and Commercial Batches of Investigational Vaccine LAWRENCEVILLE, N.J. and HAINAN, China, Sept. 17,...